Cierra N. Sharp

Cierra N. Sharp

Aug 16, 2016

Group 6 Copy 22
1
Please wait...

About This Project

A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

Blast off!

Browse Other Projects on Experiment

Related Projects

A Bird's-eye View of Frog Habitats: Using a Drone to Survey Wetlands

I study vulnerable frog species that inhabit human-constructed wetlands in the Grand River Grasslands of...

Are cryptic characteristics preventing the protection of two similar Sphingidae moths?

This project is aimed at understanding the morphological differences between two species of Sphingidae...

Seeking Safer Skies for Haiti's Rarest Seabird

The goal of our research is to reduce collisions of critically endangered Black-Capped Petrel with communication...

Backer Badge Funded